Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets

With the recent interest of protease-activated receptors (PAR) 1 and PAR4 as possible targets for the treatment of thrombotic disorders, we compared the efficacy of protease-activated receptor (PAR)1 and PAR4 in the generation of procoagulant phenotypes on platelet membranes. PAR4-activating peptide...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Duvernay, Matthew, Young, Summer, Gailani, David, Schoenecker, Jonathan, Hamm, Heidi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The American Society for Pharmacology and Experimental Therapeutics 2013
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3608438/
https://ncbi.nlm.nih.gov/pubmed/23307185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.112.083477
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak